Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus J Schwarz

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Dialogues in Clinical Neuroscience|October 29, 2011
Cytokines, neurophysiology, neuropsychology, and psychiatric symptomsMarkus J Schwarz
European Archives of Psychiatry and Clinical Neuroscience|July 3, 2008
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disordersNorbert Müller, Markus J Schwarz
Current Pharmaceutical Design|June 10, 2008
COX-2 inhibition in schizophrenia and major depressionNorbert Müller, Markus J Schwarz
Current Immunology Reviews|November 9, 2010
Immune System and SchizophreniaNorbert Müller, Markus J Schwarz
Expert Review of Neurotherapeutics|July 13, 2006
Neuroimmune-endocrine crosstalk in schizophrenia and mood disordersNorbert Müller, Markus J Schwarz
Dialogues in Clinical Neuroscience|October 29, 2011
The role of substance P in depression: therapeutic implicationsMarkus J Schwarz, Manfred Ackenheil
Therapeutic Drug Monitoring|October 14, 2006
Clinical relevance of TDM of SSRIsMarkus J Schwarz, Christoph Hiemke, Pierre Baumann, et al.
Pharmacology & Therapeutics|June 28, 2011
Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyondUrs Meyer, Markus J Schwarz, Norbert Müller
Advances in Protein Chemistry and Structural Biology|July 21, 2012
Inflammation in schizophreniaNorbert Müller, Aye-Mu Myint, Markus J Schwarz
Journal of Neural Transmission (Vienna, Austria : 1996)|December 6, 2011
The role of the kynurenine metabolism in major depressionAye-Mu Myint, Markus J Schwarz, Norbert Müller
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Dialogues in Clinical Neuroscience|October 29, 2011
Cytokines, neurophysiology, neuropsychology, and psychiatric symptomsMarkus J Schwarz
European Archives of Psychiatry and Clinical Neuroscience|July 3, 2008
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disordersNorbert Müller, Markus J Schwarz
Current Pharmaceutical Design|June 10, 2008
COX-2 inhibition in schizophrenia and major depressionNorbert Müller, Markus J Schwarz
Current Immunology Reviews|November 9, 2010
Immune System and SchizophreniaNorbert Müller, Markus J Schwarz
Expert Review of Neurotherapeutics|July 13, 2006
Neuroimmune-endocrine crosstalk in schizophrenia and mood disordersNorbert Müller, Markus J Schwarz
Dialogues in Clinical Neuroscience|October 29, 2011
The role of substance P in depression: therapeutic implicationsMarkus J Schwarz, Manfred Ackenheil
Therapeutic Drug Monitoring|October 14, 2006
Clinical relevance of TDM of SSRIsMarkus J Schwarz, Christoph Hiemke, Pierre Baumann, et al.
Pharmacology & Therapeutics|June 28, 2011
Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyondUrs Meyer, Markus J Schwarz, Norbert Müller
Advances in Protein Chemistry and Structural Biology|July 21, 2012
Inflammation in schizophreniaNorbert Müller, Aye-Mu Myint, Markus J Schwarz
Journal of Neural Transmission (Vienna, Austria : 1996)|December 6, 2011
The role of the kynurenine metabolism in major depressionAye-Mu Myint, Markus J Schwarz, Norbert Müller
Pageof 8